<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-24T11:37:23+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>DS-8201获CDE拟突破性疗法认定， 治疗胃癌或食管胃结合部腺癌</title>
    <updated>2020-12-24T07:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/IeVXwgSDPbp0bYfYMPfjig</id>
    <link href="https://mp.weixin.qq.com/s/IeVXwgSDPbp0bYfYMPfjig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>姜宝红点评 | Nature：心血管疾病诊断和治疗新靶点——ALDH4A1</title>
    <updated>2020-12-24T07:53:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/tc3e7IOW7GmR7qztmyLeLQ</id>
    <link href="https://mp.weixin.qq.com/s/tc3e7IOW7GmR7qztmyLeLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature：semorinemab阿尔茨海默症II期临床失败，靶向Tau蛋白还有哪些希望？</title>
    <updated>2020-12-23T08:48:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/BoFOdQ-sbAcildHR_HwAmw</id>
    <link href="https://mp.weixin.qq.com/s/BoFOdQ-sbAcildHR_HwAmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双特异性抗体KN026与KN046联合疗法获美国FDA孤儿药资格认定，用于治疗胃癌及胃食管连接部癌</title>
    <updated>2020-12-23T08:48:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/oxxEzP03e-kDSXZo2Dphpw</id>
    <link href="https://mp.weixin.qq.com/s/oxxEzP03e-kDSXZo2Dphpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康tezepelumab一项重度哮喘III期研究失利</title>
    <updated>2020-12-23T08:48:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/05E7BbUQxC4PJ3kbeAqo2A</id>
    <link href="https://mp.weixin.qq.com/s/05E7BbUQxC4PJ3kbeAqo2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1医保谈判&amp;竞争格局，7张图全分析</title>
    <updated>2020-12-22T08:59:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/bfRneC0RA1BuVXumMkA62w</id>
    <link href="https://mp.weixin.qq.com/s/bfRneC0RA1BuVXumMkA62w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>皮下注射PD-L1单抗KN035上市申请获CDE受理！治疗MSI-H/dMMR实体瘤</title>
    <updated>2020-12-22T08:59:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/rsXmWdnXiBVp9_ounZu2zA</id>
    <link href="https://mp.weixin.qq.com/s/rsXmWdnXiBVp9_ounZu2zA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向线粒体抗癌获突破！Nature：POLRMT变构抑制剂有效抗肿瘤，对健康细胞无显著影响</title>
    <updated>2020-12-22T08:59:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/jGso1cxvSPg21O0qdkAYkA</id>
    <link href="https://mp.weixin.qq.com/s/jGso1cxvSPg21O0qdkAYkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>苏州新芽基因完成首轮融资：国内首家专注于碱基编辑技术商业化的公司</title>
    <updated>2020-12-22T08:59:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/xb6L7mPgVkbJ65mn6VytBA</id>
    <link href="https://mp.weixin.qq.com/s/xb6L7mPgVkbJ65mn6VytBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物泰它西普IgA肾病适应症获美国FDA批准进入II期临床</title>
    <updated>2020-12-22T08:59:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/EguAZ32mtreu4C9VQxYxUQ</id>
    <link href="https://mp.weixin.qq.com/s/EguAZ32mtreu4C9VQxYxUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RNAi疗法：走出至暗时刻，全新时代已来</title>
    <updated>2020-12-21T07:45:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/i-bEbcvfT12EQ-Rs1EBBzw</id>
    <link href="https://mp.weixin.qq.com/s/i-bEbcvfT12EQ-Rs1EBBzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA发出完全回复信！诺华重磅RNAi降脂药inclisiran美国上市推迟</title>
    <updated>2020-12-21T07:45:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/UMQjiWhCWe5J7dKoU8hANA</id>
    <link href="https://mp.weixin.qq.com/s/UMQjiWhCWe5J7dKoU8hANA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华领医药公布首创降糖药52周数据，多扎格列艾汀商业化在即</title>
    <updated>2020-12-21T07:45:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/BpUrU23kezCdRK8V7xZezA</id>
    <link href="https://mp.weixin.qq.com/s/BpUrU23kezCdRK8V7xZezA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>前线治疗获批上市！FDA批准XPOVIO®用于治疗接受过至少一线治疗的多发性骨髓瘤患者</title>
    <updated>2020-12-21T07:45:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/bITabWznK4OjzcFFSBf2vQ</id>
    <link href="https://mp.weixin.qq.com/s/bITabWznK4OjzcFFSBf2vQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，这19家中国公司获得35项FDA孤儿药资格</title>
    <updated>2020-12-20T08:59:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/v1MBhYlmo3AMIzEKfrEeTg</id>
    <link href="https://mp.weixin.qq.com/s/v1MBhYlmo3AMIzEKfrEeTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高筑墙、广积粮 ! 加科思打造KRAS王国</title>
    <updated>2020-12-19T08:22:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/6fJdo3tFVLAhC4l2GD_MLg</id>
    <link href="https://mp.weixin.qq.com/s/6fJdo3tFVLAhC4l2GD_MLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚组分析，失败临床研究的一线生机？</title>
    <updated>2020-12-19T08:22:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/ykie4JfLTnk1Jy930M7nuw</id>
    <link href="https://mp.weixin.qq.com/s/ykie4JfLTnk1Jy930M7nuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物分析专栏 | 前体药物的生物分析</title>
    <updated>2020-12-18T07:55:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/6N2gnMHMA2RF_xAjphOCJA</id>
    <link href="https://mp.weixin.qq.com/s/6N2gnMHMA2RF_xAjphOCJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell：癌症免疫治疗新靶点——PHD3</title>
    <updated>2020-12-18T07:55:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/YAeB5ykBHL_9AgF8nrnWdg</id>
    <link href="https://mp.weixin.qq.com/s/YAeB5ykBHL_9AgF8nrnWdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1医保谈判尘埃落定：价格结果秘而不宣，产能比拼枕戈待旦</title>
    <updated>2020-12-17T07:38:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/oEcjopAMg8fY8KMIk3pogg</id>
    <link href="https://mp.weixin.qq.com/s/oEcjopAMg8fY8KMIk3pogg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>